AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Enlivex Therapeutics Ltd. (ENLV)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.11

-0.02 (-1.77%)

At close: Jan 29, 2025, 3:52 PM

1.11

0.09%

After-hours Jan 29, 2025, 05:13 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	n/a	n/a	n/a	2.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	835.00K	777.00K	546.00K	286.00K	297.00K	121.00K	12.00K	25.00K	17.00K	n/a	n/a	n/a
Gross Profit	-835.00K	-777.00K	-546.00K	1.99M	-297.00K	-121.00K	-12.00K	-25.00K	-17.00K	n/a	n/a	n/a
Operating Income	-29.39M	-25.80M	-19.29M	-9.79M	-8.62M	-5.30M	-5.96M	-15.87M	-15.48M	-7.08M	-1.15M	-226.00K
Interest Income	1.56M	835.00K	120.00K	225.00K	238.00K	138.00K	39.00K	90.00K	186.00K	85.00K	n/a	n/a
Pretax Income	-29.07M	-31.06M	-14.47M	-11.82M	-9.38M	-4.24M	-5.92M	-15.81M	-15.34M	-7.02M	-1.15M	-229.00K
Net Income	-29.07M	-42.41M	-9.65M	-13.86M	-10.15M	-4.24M	-5.95M	-16.02M	-15.37M	-7.02M	-1.15M	-229.00K
Selling & General & Admin	6.14M	6.70M	6.24M	3.60M	2.75M	937.00K	3.44M	6.99M	7.78M	2.64M	416.00K	86.00K
Research & Development	19.23M	18.69M	12.88M	6.09M	5.72M	4.25M	2.52M	8.88M	7.69M	4.44M	732.00K	140.00K
Other Expenses	4.02M	402.00K	167.00K	97.00K	145.00K	n/a	n/a	n/a	-829.00K	n/a	n/a	n/a
Operating Expenses	29.39M	25.80M	19.29M	9.79M	8.62M	5.30M	5.96M	15.87M	15.48M	7.08M	1.15M	226.00K
Interest Expense	14.00K	5.26M	328.00K	6.00K	7.00K	n/a	n/a	n/a	n/a	n/a	2.00K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	479.00K	n/a	829.00K	n/a	n/a	n/a
Cost & Expenses	29.39M	25.80M	19.29M	9.79M	8.62M	5.30M	5.96M	15.87M	15.48M	7.08M	1.15M	226.00K
Income Tax	n/a	11.35M	-4.82M	2.04M	765.00K	1.06M	28.00K	216.00K	24.00K	n/a	2.00K	n/a
Shares Outstanding (Basic)	18.57M	18.39M	17.86M	13.17M	8.65M	3.51M	414.20K	397.65K	355.76K	306.49K	271.85K	271.85K
Shares Outstanding (Diluted)	18.57M	18.39M	17.86M	13.17M	8.65M	3.51M	428.24K	397.65K	355.76K	306.49K	271.85K	271.85K
EPS (Basic)	-1.56	-2.31	-0.54	-1.05	-1.17	-1.21	-14.35	-40.29	-43.19	-22.91	-4.21	-0.84
EPS (Diluted)	-1.56	-2.31	-0.54	-1.05	-1.17	-1.21	-13.88	-40.29	-43.19	-22.91	-4.21	-0.84
EBITDA	-28.22M	-25.02M	-18.74M	-9.50M	-9.08M	-5.18M	-5.91M	-15.78M	-15.31M	-7.08M	-1.14M	-226.00K
Depreciation & Amortization	835.00K	777.00K	546.00K	286.00K	297.00K	121.00K	12.00K	25.00K	17.00K	5.00K	5.00K	n/a